Krishna Institute of Medical Sciences Ltd

Krishna Institu. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Krishna Institute of Medical Sciences Ltd

₹ 686 0.11%
27 Nov 3:40 p.m.
kimshospitals.com BSE: 543308 NSE: KIMS
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]

Website BSE NSE
  • Market Cap ₹ 27,430 Cr.
  • Current Price ₹ 686
  • High / Low ₹ 798 / 474
  • Stock P/E 83.4
  • Book Value ₹ 56.7
  • Dividend Yield 0.00 %
  • ROCE 15.0 %
  • ROE 18.5 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 12.0 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -4.73%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
564 562 576 606 652 606 634 688 777 772 797 872 961
412 411 413 449 475 459 475 509 559 585 599 679 757
Operating Profit 152 151 163 157 177 147 159 179 218 187 198 193 204
OPM % 27% 27% 28% 26% 27% 24% 25% 26% 28% 24% 25% 22% 21%
24 6 5 3 3 3 4 5 5 18 15 7 4
Interest 8 12 5 9 9 12 16 18 20 26 27 33 45
Depreciation 31 33 35 32 33 35 46 39 41 45 53 53 66
Profit before tax 137 113 127 119 139 102 100 127 162 135 134 114 97
Tax % 23% 27% 22% 27% 27% 25% 28% 25% 26% 31% 21% 25% 26%
106 82 99 87 101 77 72 95 121 92 106 85 72
EPS in Rs 2.43 1.90 2.33 2.02 2.30 1.80 1.64 2.16 2.68 2.22 2.54 1.96 1.67
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
512 567 664 918 1,123 1,330 1,651 2,198 2,498 3,035 3,402
403 450 593 833 872 953 1,126 1,587 1,850 2,242 2,620
Operating Profit 109 118 71 85 251 377 524 611 648 793 782
OPM % 21% 21% 11% 9% 22% 28% 32% 28% 26% 26% 23%
5 3 37 6 5 9 27 41 13 43 44
Interest 37 32 88 49 44 37 22 37 55 100 130
Depreciation 36 35 40 56 71 70 73 129 147 177 217
Profit before tax 41 53 -20 -15 141 279 457 485 460 558 479
Tax % 32% 37% 126% 223% 18% 26% 25% 25% 27% 26%
28 33 -46 -49 115 205 344 366 336 415 356
EPS in Rs 0.76 0.91 -1.32 -1.28 3.20 5.19 8.32 8.41 7.75 9.61 8.39
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 22%
3 Years: 23%
TTM: 26%
Compounded Profit Growth
10 Years: %
5 Years: 25%
3 Years: 3%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 32%
1 Year: 16%
Return on Equity
10 Years: %
5 Years: 22%
3 Years: 19%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 70 72 50 74 74 78 80 80 80 80 80
Reserves 193 255 -209 466 524 786 1,307 1,590 1,748 2,058 2,190
256 280 753 336 369 316 257 678 1,355 2,557 3,187
146 167 359 237 228 253 260 553 636 995 1,168
Total Liabilities 665 774 954 1,114 1,194 1,433 1,904 2,901 3,820 5,689 6,625
515 518 755 863 916 931 1,005 1,766 2,434 3,348 4,642
CWIP 2 64 0 0 2 9 21 477 600 1,214 573
Investments 11 14 0 0 0 0 332 68 157 99 98
137 177 199 250 276 493 546 590 629 1,028 1,312
Total Assets 665 774 954 1,114 1,194 1,433 1,904 2,901 3,820 5,689 6,625

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
95 82 106 134 202 356 324 432 521 582
-41 -100 -64 -110 -125 -354 -412 -416 -753 -1,116
-65 24 -39 -27 -44 10 61 20 217 543
Net Cash Flow -11 5 3 -3 32 12 -26 36 -15 9

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 47 59 59 49 43 30 28 42 43 48
Inventory Days 36 43 46 47 44 30 37
Days Payable 194 207 215 181 177 167 133
Cash Conversion Cycle -111 -105 -110 -85 -91 -106 -67 42 43 48
Working Capital Days 11 26 -333 -15 -15 -31 -3 8 -5 -29
ROCE % 15% 11% 5% 20% 29% 34% 24% 17% 15%

Shareholding Pattern

Numbers in percentages

3 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
38.85% 38.85% 38.85% 38.85% 38.82% 38.82% 38.82% 38.82% 38.82% 38.82% 34.11% 34.11%
20.50% 19.41% 13.15% 14.24% 15.27% 16.73% 17.84% 15.85% 15.68% 15.44% 15.54% 15.03%
28.32% 29.76% 35.77% 34.80% 34.24% 33.13% 32.12% 32.29% 32.05% 31.95% 31.65% 32.12%
12.34% 11.99% 12.23% 12.10% 11.67% 11.32% 11.22% 13.03% 13.45% 13.78% 18.68% 18.74%
No. of Shareholders 63,36260,98065,44966,95771,01469,09269,06377,61795,4681,01,8951,08,9551,04,872

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls